Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Alveolar Soft Part | 2 | 2018 | 9 | 0.850 |
Why?
|
| Consultants | 1 | 2021 | 12 | 0.720 |
Why?
|
| Pathology, Surgical | 1 | 2021 | 16 | 0.720 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2022 | 106 | 0.690 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 36 | 0.590 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2018 | 128 | 0.520 |
Why?
|
| Strongylida Infections | 1 | 2016 | 14 | 0.510 |
Why?
|
| Antigens, CD | 1 | 2018 | 415 | 0.510 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2016 | 131 | 0.480 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 46 | 0.450 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 61 | 0.450 |
Why?
|
| Polyps | 1 | 2015 | 40 | 0.440 |
Why?
|
| Peritoneal Neoplasms | 1 | 2015 | 53 | 0.430 |
Why?
|
| Endometrial Neoplasms | 1 | 2015 | 108 | 0.420 |
Why?
|
| Colorectal Neoplasms | 4 | 2025 | 623 | 0.410 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2012 | 25 | 0.380 |
Why?
|
| Lipoma | 1 | 2011 | 24 | 0.360 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2011 | 43 | 0.350 |
Why?
|
| Cicatrix | 1 | 2012 | 122 | 0.350 |
Why?
|
| Alagille Syndrome | 2 | 2023 | 51 | 0.340 |
Why?
|
| Ulcer | 1 | 2010 | 51 | 0.310 |
Why?
|
| Endometriosis | 1 | 2012 | 170 | 0.310 |
Why?
|
| Cesarean Section | 1 | 2012 | 424 | 0.290 |
Why?
|
| Testicular Neoplasms | 1 | 2010 | 120 | 0.290 |
Why?
|
| Population Surveillance | 2 | 2022 | 395 | 0.290 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 257 | 0.290 |
Why?
|
| Paragonimiasis | 1 | 2008 | 1 | 0.290 |
Why?
|
| Paragonimus | 1 | 2008 | 1 | 0.290 |
Why?
|
| Lung Diseases, Parasitic | 1 | 2008 | 13 | 0.280 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 216 | 0.270 |
Why?
|
| Diagnosis, Differential | 5 | 2018 | 1867 | 0.260 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2005 | 4 | 0.240 |
Why?
|
| Ear Neoplasms | 1 | 2005 | 14 | 0.240 |
Why?
|
| Asphyxia | 1 | 2005 | 12 | 0.230 |
Why?
|
| Oropharynx | 1 | 2005 | 31 | 0.230 |
Why?
|
| Fructose | 1 | 2025 | 60 | 0.230 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2025 | 40 | 0.230 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2005 | 61 | 0.230 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 880 | 0.220 |
Why?
|
| Eosinophils | 1 | 2005 | 123 | 0.220 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 591 | 0.210 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 90 | 0.210 |
Why?
|
| Foreign Bodies | 1 | 2005 | 102 | 0.210 |
Why?
|
| Liver | 2 | 2023 | 1765 | 0.210 |
Why?
|
| Humans | 29 | 2025 | 127455 | 0.200 |
Why?
|
| Glycosyltransferases | 1 | 2023 | 26 | 0.200 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 302 | 0.200 |
Why?
|
| SOX9 Transcription Factor | 2 | 2023 | 87 | 0.200 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2023 | 69 | 0.190 |
Why?
|
| Pyrazoles | 1 | 2025 | 330 | 0.190 |
Why?
|
| Meningioma | 1 | 2024 | 113 | 0.190 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 63 | 0.180 |
Why?
|
| Meningeal Neoplasms | 1 | 2024 | 181 | 0.180 |
Why?
|
| Pathologists | 1 | 2021 | 26 | 0.180 |
Why?
|
| Middle Aged | 10 | 2025 | 27867 | 0.180 |
Why?
|
| Coccidioidomycosis | 1 | 2021 | 9 | 0.170 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2021 | 14 | 0.170 |
Why?
|
| Glucose | 1 | 2025 | 839 | 0.170 |
Why?
|
| Glucosyltransferases | 2 | 2023 | 39 | 0.170 |
Why?
|
| Airway Obstruction | 2 | 2017 | 176 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 235 | 0.160 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3073 | 0.160 |
Why?
|
| User-Computer Interface | 1 | 2001 | 155 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 711 | 0.160 |
Why?
|
| Stomach | 1 | 2022 | 267 | 0.150 |
Why?
|
| Triage | 1 | 2001 | 151 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 2 | 2023 | 327 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2023 | 289 | 0.150 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 278 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2025 | 1032 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 438 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2001 | 199 | 0.140 |
Why?
|
| Exophthalmos | 1 | 2018 | 30 | 0.140 |
Why?
|
| Granulation Tissue | 1 | 2017 | 12 | 0.140 |
Why?
|
| Internet | 1 | 2001 | 406 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2021 | 562 | 0.140 |
Why?
|
| Heterozygote | 2 | 2020 | 691 | 0.130 |
Why?
|
| Orbital Neoplasms | 1 | 2018 | 45 | 0.130 |
Why?
|
| Tracheotomy | 1 | 2017 | 35 | 0.130 |
Why?
|
| Orbit | 1 | 2018 | 79 | 0.130 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 58 | 0.130 |
Why?
|
| Strongylida | 1 | 2016 | 1 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 753 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 743 | 0.130 |
Why?
|
| Male | 11 | 2025 | 62861 | 0.130 |
Why?
|
| Cerebrospinal Fluid | 1 | 2016 | 96 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 713 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 565 | 0.120 |
Why?
|
| Bile Duct Diseases | 1 | 2015 | 16 | 0.120 |
Why?
|
| Adult | 8 | 2025 | 30579 | 0.120 |
Why?
|
| Jagged-1 Protein | 3 | 2023 | 51 | 0.120 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2015 | 10 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1600 | 0.110 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 260 | 0.110 |
Why?
|
| Mediastinitis | 1 | 2012 | 16 | 0.100 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 68 | 0.100 |
Why?
|
| Sclerosis | 1 | 2012 | 29 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2023 | 1569 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 689 | 0.100 |
Why?
|
| Amyloidosis | 1 | 2013 | 71 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2015 | 769 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 1239 | 0.090 |
Why?
|
| Female | 9 | 2025 | 68733 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3937 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2013 | 286 | 0.090 |
Why?
|
| Animals | 6 | 2025 | 33205 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 443 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 2048 | 0.090 |
Why?
|
| Myxoma | 1 | 2010 | 29 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 2587 | 0.080 |
Why?
|
| Serrate-Jagged Proteins | 2 | 2023 | 36 | 0.080 |
Why?
|
| Heart Neoplasms | 1 | 2010 | 105 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2012 | 640 | 0.070 |
Why?
|
| Ovum | 1 | 2008 | 15 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1561 | 0.070 |
Why?
|
| Keratosis | 1 | 2005 | 17 | 0.060 |
Why?
|
| NAD | 1 | 2025 | 50 | 0.060 |
Why?
|
| Inhalation | 1 | 2005 | 8 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 99 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2005 | 40 | 0.060 |
Why?
|
| Arteriovenous Malformations | 1 | 2005 | 47 | 0.060 |
Why?
|
| Glycolysis | 1 | 2025 | 169 | 0.060 |
Why?
|
| Mice | 4 | 2025 | 17693 | 0.050 |
Why?
|
| Biopsy | 2 | 2022 | 1237 | 0.050 |
Why?
|
| Echocardiography | 1 | 2010 | 1115 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2005 | 359 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2024 | 17 | 0.050 |
Why?
|
| Trachea | 1 | 2005 | 204 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 611 | 0.050 |
Why?
|
| Mitosis | 1 | 2024 | 190 | 0.050 |
Why?
|
| Radiography | 1 | 2005 | 755 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2023 | 104 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 39 | 0.050 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2022 | 52 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2022 | 45 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2023 | 224 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2025 | 403 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 852 | 0.050 |
Why?
|
| Incidence | 2 | 2022 | 3263 | 0.050 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 77 | 0.040 |
Why?
|
| Pancreas | 1 | 2022 | 215 | 0.040 |
Why?
|
| Expert Systems | 1 | 2001 | 15 | 0.040 |
Why?
|
| Texas | 2 | 2022 | 3565 | 0.040 |
Why?
|
| Metaplasia | 1 | 2022 | 213 | 0.040 |
Why?
|
| Cholestasis | 1 | 2023 | 166 | 0.040 |
Why?
|
| Aged | 3 | 2025 | 20494 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 351 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2020 | 52 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2020 | 58 | 0.040 |
Why?
|
| Child | 3 | 2022 | 25296 | 0.040 |
Why?
|
| Risk | 1 | 2001 | 735 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4514 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 231 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2020 | 195 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3503 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 2017 | 32 | 0.030 |
Why?
|
| Prognosis | 1 | 2007 | 4803 | 0.030 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2018 | 74 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2020 | 14462 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 179 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 150 | 0.030 |
Why?
|
| Software | 1 | 2001 | 712 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2025 | 4987 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2017 | 215 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1142 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 1892 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 285 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 489 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17076 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 6716 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 979 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 4309 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 5160 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1235 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3694 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 188 | 0.020 |
Why?
|
| Pregnancy | 1 | 2005 | 7423 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2013 | 85 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 227 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 2111 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2999 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2013 | 225 | 0.020 |
Why?
|
| Diarrhea | 1 | 2013 | 305 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 452 | 0.020 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2010 | 61 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 1539 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 12580 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4445 | 0.020 |
Why?
|
| Adolescent | 1 | 2007 | 20154 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4489 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10631 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 12806 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9703 | 0.010 |
Why?
|